Vero Bioscience, Inc.

Welcome back to the Ages Podcast.

Today's guest is Paul Coletta, co-founder and CEO of Vero Bioscience.

Paul spent around 30 years building consumer brands, big names, Disney, HP, Viacom, Herman Remedy, before starting Vero at the ripe old age of 61, after a friend talked him into taking a proteomics test built on research out of Stanford.

That single vial of blood found his kidney was aging seven years faster than the rest of him, years before any of his standard blood work showed a thing.

And, you know, I think right now within this kind of messy phase that we're in, which is full of opportunities, we don't have any necessarily like the business models and the... you know, the product category, like everything hasn't been pulled together and there's going to be multiple ones that can win in this category, but you know, it's just a lot going on.

There's a lot of new products like Vero Bioscience is a client of mine.

They offer proteomics now, which is super interesting.

Like you can tell how fast your organs are aging over the next 17 years and gives you interventions on how to do it.

Hey, everyone.

In this episode, we sat down with Paul Coletta, co-founder and CEO of Vero Bioscience.

Vero's organ age assay measures the biological age of each organ from a single blood draw, and its Vero Compass platform turns that reading into a targeted action plan.

Paul built his career on storytelling and consumer marketing, starting with a decade at Disney before leading brand and product marketing roles at MTV Networks, Nickelodeon, and Hewlett-Packard.

I expect to see more founders, more CEOs, maybe with a bit of a background like yourself, with a ton of consumer chops.

With that said, we're going to certainly get into a lot of different topics in this interview, from fundraising to how you identify an idea maybe that's worth going after, to early stage prototyping and R&D stuff.

Let's talk first about Vero, Vero Bioscience.

That's the URL as well, Vero, V-E-R-O, bioscience.com. We'll link to it in the full write-up as well for the program.

But an experimental organ aging test, and who knew there was such a thing, an organ aging test gave Paul a result that he wasn't expecting and ultimately helped change the direction of his career.

Today, Paul is co-founder and CEO of Vero Bioscience, working to bring this emerging field of science into wider use.

So what does it mean to have an old organ? How reliable are these tests? And if one part of our body is aging faster, first of all, does it matter? And if it does, can we do anything about it? So many questions.

Paul, welcome to the Live Long podcast.

This is the Live Long podcast.

Our guest is Paul Pelletta, co-founder and

CEO of Vero Bioscience.

Let's just talk about the artificial intelligence element here.